Showing results (131-140 of 302) with videos related to
Sort By:
Pageof 31
Journal of the American Academy of Dermatology|December 3, 2023
Histopathologic regression in patients with primary cutaneous melanoma undergoing sentinel lymph node biopsy is associated with favorable survival and, after metastasis, with improved progression-free survival on immune checkpoint inhibitor therapy: A single-institutional cohort studyNikolaus B Wagner, Sarah M Knierim, Felix Luttermann, et al.Plos One|November 22, 2013
TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinomaKlaus G Griewank, Rajmohan Murali, Bastian Schilling, et al.Cancer Immunology, Immunotherapy : CII|April 18, 2019
MHC class-I downregulation in PD-1/PD-L1 inhibitor refractory Merkel cell carcinoma and its potential reversal by histone deacetylase inhibition: a case seriesSelma Ugurel, Ivelina Spassova, Jonas Wohlfarth, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 20, 2026
Development and validation of the Essen Melanoma Quality of Life Inventory (EMQoLI)Venja Musche, Theresa Schadendorf, Adam Schweda, et al.Cancers|March 11, 2023
Tolerability of BRAF and MEK Inhibitors for Metastasized Melanoma after Intra-Class Switch: A Multicenter, Retrospective StudyMartin Salzmann, Alexander Wald, Henner Stege, et al.European Journal of Cancer (Oxford, England : 1990)|March 13, 2022
Genetic characterization of advanced conjunctival melanoma and response to systemic treatmentGeorg C Lodde, Philipp Jansen, Inga Möller, et al.ESMO Open|June 25, 2019
Tolerability of BRAF/MEK inhibitor combinations: adverse event evaluation and managementLucie Heinzerling, Thomas K Eigentler, Michael Fluck, et al.Cancers|March 1, 2020
MDM2, MDM4 and EGFR Amplifications and Hyperprogression in Metastatic Acral and Mucosal MelanomaAndrea Forschner, Franz-Joachim Hilke, Irina Bonzheim, et al.Nature Communications|October 9, 2024
Tumour-informed liquid biopsies to monitor advanced melanoma patients under immune checkpoint inhibitionChristopher Schroeder, Sergios Gatidis, Olga Kelemen, et al.Journal of Clinical Medicine|July 8, 2020
ECG Changes in Melanoma Patients Undergoing Cancer Therapy-Data From the ECoR RegistryJulia Pohl, Raluca-Ileana Mincu, Simone Maria Mrotzek, et al.Pageof 31